| FA158666 |
59-53-0 |
N-Acetyl-DL-penicillamine |
|
Protective agent against mercuric chloride poisoning |
|
| BA173042 |
1415036-82-6 |
AGN 220653 |
|
|
|
| FA01736 |
90058-29-0 |
Alaptide |
|
Nootropic agent; affects dopaminergic system |
|
| FA17279 |
26750-81-2 |
Alibendol |
|
Anti-spasmodic, choleretic and cholekinetic agent |
|
| FA17334 |
645-05-6 |
Altretamine |
|
Alkylating agent; cytotoxic; antineoplastic |
|
| FA17353 |
20537-88-6 |
Amifostine |
|
Radio- and chemoprotective agent |
|
| W-105849 |
521-17-5 |
5-Androstenediol |
|
|
|
| FA73663 |
113-80-4 |
[Arg8]-Vasotocin trifluoroacetate |
|
|
|
| FA17994 |
88495-63-0 |
Artesunate |
|
Prodrug of dihydroartemisin (DHA); antimalarial |
|
| FA172879 |
1176760-49-8 |
AZD 4877 |
|
|
|
| FB18131 |
80573-04-2 |
Balsalazide |
|
Prodrug of 5-aminosalicylic acid; anti-inflammatory |
BIO-X |
| FB18146 |
138356-09-9 |
BD 1008 dihydrobromide |
|
Sigma (σ) receptor antagonist |
BIO-X |
| FB18147 |
150208-28-9 |
BD 1063 |
|
Antagonist of σ1 receptor |
BIO-X |
| FB18148 |
191744-13-5 |
BDP 37 |
|
|
BIO-X |
| FB171048 |
86541-75-5 |
Benazepril |
|
|
|
| FB18170 |
19428-14-9 |
Benproperine phosphate |
|
Anti-tussive agent |
|
| FM162104 |
1622988-14-0 |
cis-Benvitimod |
|
Aryl hydrocarbon receptor (AhR) agonist |
|
| FD167852 |
79338-84-4 |
Benvitimod |
|
Aryl hydrocarbon receptor (AhR) agonist |
|
| FB18200 |
68-90-6 |
Benziodarone |
|
Uricosuric agent |
|
| IC58278 |
90357-06-5 |
Bicalutamide |
|
Androgen receptor antagonist |
|
| FB18605 |
576-19-2 |
Biocytin |
|
|
|
| FB168813 |
1407495-02-6 |
Bococizumab |
|
|
|
| FB170950 |
1607799-13-2 |
Bremelanotide acetate |
|
|
|
| BB162705 |
76455-48-6 |
4-Bromo-A23187 |
|
Non-fluorescent Ca2+ ionophore; for calibrating fluorescent Ca2+ probes |
|
| FA103795 |
262442-90-0 |
BSF-466895 |
|
|
|
| FB19345 |
65002-17-7 |
Bucillamine |
|
Potential treatment for gout and rheumatoid arthritis |
|
| FC171039 |
77107-46-1 |
Calmodulin |
|
|
|
| BC162800 |
577696-37-8 |
Cardionogen 1 |
|
Promotes cardiomyocyte generation |
|
| FC175578 |
443798-55-8 |
Cdk1/2 Inhibitor III |
|
|
|
| BC164299 |
27724-96-5
34675-84-8 |
Cetraxate hydrochloride |
|
Anti-ulcerative agent |
|
| FC20409 |
94-20-2 |
Chlorpropamide |
|
Hypoglycemic agent |
|
| FC20416 |
95-25-0
202-403-9 |
Chlorzoxazone |
|
Muscle relaxant; treats muscle spasms |
|
| BC164318 |
4291-63-8 |
Cladribine |
|
Deoxyadenosine analog resistant to adenosine deaminase |
BIO-X |
| BC167259 |
130-26-7 |
Clioquinol |
|
Anti-infective agent against diarrhoea; chelating application for Alzheimer’s |
|
| FC161383 |
71923-34-7 |
Clodoxopone |
|
Hypolipidemic agent |
|
| BC166450 |
|
CMP 98 |
|
Negative control for CM11; no effect on VHL E3 ubiquitin ligase |
|
| FC161379 |
4366-18-1 |
Coumetarol |
|
Anti-coagulant |
|
| FA145499 |
125314-13-8 |
CP 21 |
|
|
|
| EC70361 |
6190-45-0 |
Creatine phosphate disodium salt hexahydrate |
|
Phosphate reservoir in muscles, aiding conversion of ADP to ATP |
|
| FC108671 |
86784-80-7 |
CRF (human, rat) acetate |
|
|
|
| FC138959 |
172430-48-7 |
CVT 3369 |
|
Metabolite of ranolazine |
|
| FC55888 |
2491-17-0 |
N-Cyclohexyl-N'-(2-morpholinoethyl)carbodiimide methyl-p-toluenesulfonate |
|
Carbodiimide used to detect pseudouridine in RNA |
|
| FA108700 |
100929-53-1 |
DAMGO acetate |
|
μ-opioid receptor agonist |
|
| BD174973 |
950492-85-0 |
DAMGO (TFA) |
|
|
|
| FA109659 |
106362-34-9 |
DAPTA |
|
|
|
| FB20882 |
201530-41-8 |
Deferasirox |
|
Tridentate iron chelator |
|
| FD64999 |
554435-83-5 |
Deferasirox Fe3+ Chelate |
|
Iron chelator |
|
| FD21050 |
148-51-6 |
4-Deoxypyridoxine hydrochloride |
|
Vitamin B6 antimetabolite |
|
| BD170166 |
120444-72-6 |
Deramciclane fumarate |
|
Non-benzodiazepine-type anxiolytic drug; used various types of anxiety disorders |
|
| FE125049 |
10045-45-1 |
1-EBIO |
|
|
|